Optimizing Cell Culture for Immune Cell Therapy Manufacturing
This webinar introduces a flexible two-component medium system designed to support the specific needs of different immune cell types.
This webinar introduces a flexible two-component medium system designed to support the specific needs of different immune cell types.
Endpoints 11 is more than a list. It's a night where founders, investors and the editors who follow them come together in one room.
Join Alliant and Bio-EV for a community pickle ball happy hour with the San Diego biotech community.
Join the American Diabetes Association® along with your friends, family, and colleagues as we ride in support of people living with diabetes. Tour de Cure® is the moment for corporations, organizations, and individuals to come together and show our community how much we care—and how much we’ll do to end diabetes for good. By joining..
This workshop will provide an integrated overview of how safety pharmacology studies support IND‑enabling development, with a focus on regulatory expectations, evolving scientific practices, and translational decision‑making. Topics will begin with an overview of current regulatory guidance and agency expectations for safety pharmacology programs, setting the framework for study scope, timing, and interpretation. Core systems..
Endpoints 11 is more than a list. It's a night where founders, investors and the editors who follow them come together in one room.
𝗤𝘂𝗶𝘇 𝗡𝗶𝗴𝗵𝘁 𝘄𝗶𝘁𝗵 𝗖𝗮𝘁 | 𝗼𝟮𝗵 𝗰𝗼-𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 Join us for an evening of quiz, conversation and connection during 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗼𝗻 𝗧𝗮𝗿𝗴𝗲𝘁 in Boston. On Monday, 28 September, from 6:00–8:30 PM, we’re bringing together scientists, biotech professionals and curious minds for a fun quiz spanning 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀, 𝗕𝗶𝗼𝘁𝗲𝗰𝗵, 𝗣𝗼𝗽 𝗖𝘂𝗹𝘁𝘂𝗿𝗲, 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 𝗮𝗻𝗱 𝗺𝗼𝗿𝗲. Hosted by..
Attendees will gain a deeper understanding of the advantages of investing in the Los Angeles bioscience ecosystem, along with insights into how bioscience companies have successfully navigated the various stages of investment funding. The program will highlight the region’s unique opportunities for private and corporate investors while exploring the resources, partnerships, and capital landscape driving..
The rapid growth of antibody-drug conjugate (ADC) programs is creating new challenges for a CDMO execution for highly potent linker-payloads. While containment, limited material availability, and accelerated timelines are well-recognized challenges, successful scale-up and GMP manufacture often depend on solving less frequently discussed problems. These include establishing reference standards when only small quantities of material..